Author: Ken Dropiewski

BIOLIFE4D Targets High Growth Healthcare 3D Printing Market as it Readies for Regulation A+ Offering

CHICAGO, Jan. 17, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the high growth healthcare 3D printing market as the Company readies for its Regulation A+ equity crowdfunding offering. A recent report projects the global market to […]

International Biophysics Wins FDA Nod for the FloPump 32 Centrifugal Heart Pump

AUSTIN, Texas, Jan. 17, 2018 /PRNewswire/ — International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas, announced they have received FDA A 510k clearance for their FloPump 32 centrifugal disposable heart pump. The FloPump 32 is one of the smallest centrifugal pumps in the world at 32ml prime. The FloPump […]

Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft

TELFORD, Pa.–(BUSINESS WIRE)–Secant Group, in partnership with its sister company SanaVita Medical, announce game changing technology to advance cardiovascular regenerative medicine with the development of a synthetic, small bore, vessel that encourages endogenous regeneration and new vessel formation. The technology is based on the company’s sophisticated textile forming capabilities that […]

MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM

DUBLIN – January 16, 2018 – Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. The Riptide Aspiration System is designed to retrieve thrombus […]

Siemens Healthineers to Launch Cost-Cutting Drive Ahead of $49B IPO

Siemens Healthineers lays out strategy to bolster market leadership beyond 2025 London, 2018-Jan-16 Siemens Healthineers well prepared to take advantage of paradigm shift and structural growth opportunities in healthcare 2015 – 2017 performance illustrates strong financial profile Strategy aimed at accelerating profitable growth and delivering return Siemens Healthineers today laid out […]

Novoheart Files Patent Application on Three-Tier Drug Screening System After Successful Collaboration Contract with Global Pharma Company

VANCOUVER, BRITISH COLUMBIA — (Marketwired) — Jan 16, 2018 — Novoheart(“Novoheart” or the “Company”) (TSX VENTURE: NVH) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a three-tiered drug screening system with enhanced capability, sensitivity and accuracy for detecting pharmacological effects […]

CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge

HOUSTON–(BUSINESS WIRE)–CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has won First Prize in the “RESI (Redefining Early Stage Investments) San Francisco 2018” investment competition for early-stage life science companies. “We are excited that early-stage investors instantly grasp the […]

Beverly A. Huss Joins Accuray Board of Directors

SUNNYVALE, Calif., Jan. 11, 2018 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company’s Board of Directors, effective January 7, 2018. Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc., Surefire Medical, Inc., and Madorra. Her prior public company board experience includes Artes Medical, Wright […]